Kestra Medical Technologies, LTD S-1 registration statements

Kestra Medical Technologies, Ltd. filed an S-1MEF to register an additional 575,000 common shares, including 75,000 for underwriters' option, for its public offering.

Kestra Medical Technologies is launching a public offering of 5.5 million common shares to fund growth, reporting significant revenue increases and validating its ASSURE WCD's clinical benefits.

Kestra Medical Technologies seeks to register an additional 2,164,704 common shares, including those under the underwriters' option, following the effectiveness of its initial registration statement.

Kestra Medical Technologies files an amendment to its S-1 registration statement and announces the hiring of Al Ford as Chief Commercial Officer with a $500,000 base salary and significant equity grants.

Kestra Medical Technologies, a wearable medical device company, is seeking to raise capital through an initial public offering of 10 million common shares, with an expected price range of $14 to $16 per share.

Kestra Medical Technologies, a wearable medical device company, has filed an S-1 registration statement for an initial public offering (IPO) to further commercialize its Cardiac Recovery System platform and ASSURE WCD.